Literature DB >> 12714832

Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein.

Alessandro Sciahbasi1, Felicita Andreotti, Raimondo De Cristofaro, Dionigi Fischetti, Antonio Maria Leone, Giovanni Schiavoni, Attilio Maseri, Raffaele Landolfi.   

Abstract

BACKGROUND: To better understand the mechanisms linking C reactive protein (CRP) to the risk of coronary thrombosis, we investigated the relation between inflammatory state and hemostatic response to coronary angioplasty in patients with either stable or unstable angina.
METHODS: Plasma levels of von Willebrand factor (vWF) antigen, vWF collagen binding activity, vWF-cleaving-protease, CRP, and whole-blood platelet reactivity were measured before and 24 h after angioplasty in 18 patients with recent unstable angina and in 17 with stable angina. Each group was divided according to preprocedural CRP levels: >or=3 mg/l (in 9 unstable and 9 stable patients) or <3 mg/l (in 9 unstable and 8 stable patients).
RESULTS: Baseline hemostatic parameters did not differ significantly among the four subgroups of patients. After angioplasty, virtually all patients with unstable angina and raised preprocedural CRP showed increased vWF antigen (P = 0.01), vWF collagen-binding (P = 0.001), CRP (P = 0.008), and platelet reactivity (P = 0.0007) compared to baseline, whereas no significant change of these variables was seen within the other three sets of patients. In the overall population, the changes in vWF antigen and vWF-collagen-binding induced by angioplasty correlated with those in CRP levels (r = 0.47, P = 0.004 and r = 0.44, P = 0.008). Baseline levels of vWF cleaving protease and modifications of this enzyme with angioplasty did not differ significantly among subgroups.
CONCLUSIONS: Our data suggest that high preprocedural levels of CRP predict a significant vWF rise after angioplasty in patients with unstable angina. The rise in vWF is associated with that in CRP and with enhanced platelet reactivity. Such changes may contribute to the worse prognosis of unstable patients with raised indices of inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12714832     DOI: 10.1023/a:1023232928642

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  22 in total

1.  Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP)

Authors:  H E Gerritsen; P L Turecek; H P Schwarz; B Lämmle; M Furlan
Journal:  Thromb Haemost       Date:  1999-11       Impact factor: 5.249

Review 2.  von Willebrand factor.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 3.  C-reactive protein and atherothrombosis.

Authors:  M B Pepys; G M Hirschfield
Journal:  Ital Heart J       Date:  2001-03

4.  Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

Authors:  A Buffon; G Liuzzo; L M Biasucci; P Pasqualetti; V Ramazzotti; A G Rebuzzi; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

5.  A simple assay for platelet-mediated hemostasis in flowing whole blood (PFA-100): reproducibility and effects of sex and age.

Authors:  A Sestito; A Sciahbasi; R Landolfi; A Maseri; G A Lanza; F Andreotti
Journal:  Cardiologia       Date:  1999-07

6.  Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.

Authors:  G Montalescot; F Philippe; A Ankri; E Vicaut; E Bearez; J E Poulard; D Carrie; D Flammang; A Dutoit; A Carayon; C Jardel; M Chevrot; J P Bastard; F Bigonzi; D Thomas
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

7.  Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.

Authors:  G Liuzzo; A Buffon; L M Biasucci; J R Gallimore; G Caligiuri; A Vitelli; S Altamura; G Ciliberto; A G Rebuzzi; F Crea; M B Pepys; A Maseri
Journal:  Circulation       Date:  1998-12-01       Impact factor: 29.690

8.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  S G Thompson; J Kienast; S D Pyke; F Haverkate; J C van de Loo
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

9.  Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

Authors:  J L Moake; N A Turner; N A Stathopoulos; L H Nolasco; J D Hellums
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

10.  Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms.

Authors:  E J Favaloro; D Facey; L Grispo
Journal:  Am J Clin Pathol       Date:  1995-09       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.